(Q41695164)

7 October 2017

title

Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy (English)

1 reference

7 October 2017

Anne-Roos S Frenay

1

1 reference

7 October 2017

Lili Yu

2

1 reference

7 October 2017

A Rogier van der Velde

3

1 reference

7 October 2017

Inge Vreeswijk-Baudoin

4

1 reference

7 October 2017

Natalia López-Andrés

5

1 reference

7 October 2017

Harry van Goor

6

1 reference

7 October 2017

Herman H Silljé

7

1 reference

7 October 2017

Willem P Ruifrok

8

1 reference

7 October 2017

Rudolf A de Boer

9

1 reference

7 October 2017

publication date

10 December 2014

1 reference

American Journal of Physiology - Renal Physiology

7 October 2017

published in

1 reference

7 October 2017

volume

308

1 reference

7 October 2017

issue

5

1 reference

7 October 2017

page(s)

F500-9

1 reference

Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

The role of tubulointerstitial injury in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Plasticity of kidney cells: Role in kidney remodeling and scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Mechanisms of obesity-associated cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Chronic kidney disease: the global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Extracellular functions of galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Elevated galectin-3 precedes the development of CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Growth arrest specific protein 6 participates in DOCA-induced target-organ damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Protein glycation, diabetes, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Expression of galectin-3 modulates T-cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Galectins: structure, function and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00461.2014

10.1152/AJPRENAL.00461.2014

21 January 2018

Identifiers

DOI

1 reference

release_ur72r53mzfex5iyv276strmvie

7 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ur72r53mzfex5iyv276strmvie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference